Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model
Abstract Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy characterized by the accumulation of functionally incompetent B lymphocytes. Despite the availability of highly effective treatments, CLL remains incurable, and the factors contributing to disease progression are not fu...
Saved in:
Main Authors: | Lisa Pfeuffer, Viola Siegert, Riccardo Trozzo, Katja Steiger, Roland Rad, Jürgen Ruland, Maike Buchner |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-86876-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
by: Giovanni D'Arena, et al.
Published: (2013-01-01) -
Chronic Lymphocytic Leukemia and Myelofibrosis
by: Fares Darawshy, et al.
Published: (2018-01-01) -
Chronic Lymphocytic Leukemia-Associated Cholangiopathy
by: Jake Mann, et al.
Published: (2011-01-01) -
Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy
by: Ali Sakhdari, et al.
Published: (2019-01-01) -
Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
by: Patrycja Zielinska, et al.
Published: (2014-01-01)